Xofluza Cost in the United States
The price of Xofluza (baloxavir marboxil) in the United States can vary depending on factors such as dosage, pharmacy, and insurance coverage. A single prescription for Xofluza 80 mg, intended for individuals weighing 40 kg or more, typically costs around \$240. For patients weighing less than 40 kg, the dosage is adjusted, and the price may differ [1].
How Does Insurance Affect Xofluza's Price?
Insurance plans often cover a portion of Xofluza's cost. However, the exact out-of-pocket expense for patients will depend on their specific insurance plan's formulary, deductible, and copay or coinsurance requirements. Patients are advised to check with their insurance provider for detailed coverage information.
Are There Xofluza Savings Programs Available?
Xofluza offers a savings program for eligible commercially insured patients. This program can potentially reduce out-of-pocket costs. Information regarding eligibility and program details is generally available through the manufacturer's website or by asking a pharmacist [1].
What is the Difference Between Xofluza and Other Flu Treatments?
Xofluza is an antiviral medication used to treat influenza A and B infections in individuals six months of age and older. Unlike some other flu treatments that may require multiple doses, Xofluza is typically administered as a single oral dose. Its mechanism of action targets the cap-dependent endonuclease activity of the influenza virus polymerase acidic protein, inhibiting viral replication [1]. Other common flu treatments include oseltamivir (Tamiflu) and peramivir, which are administered intravenously [2].
When Does Xofluza's Patent Expire?
Information regarding the patent exclusivity of Xofluza is tracked by resources like DrugPatentWatch.com. Specific patent expiry dates can influence the potential for generic competition and market entry of biosimilar or generic versions of the drug [3].
Who Manufactures Xofluza?
Xofluza is manufactured by Shionogi Inc. [1].
What is Xofluza Used For?
Xofluza is approved for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have had flu symptoms for no more than 48 hours [1]. It is also approved for post-exposure prophylaxis of influenza in individuals 12 years of age and older to prevent influenza after close contact with an infected individual [1].
Can Xofluza Be Used for Prevention?
Yes, Xofluza is approved for post-exposure prophylaxis of influenza in individuals 12 years of age and older to prevent the flu after close contact with someone who has the infection [1].
---
Sources:
[1] Xofluza (baloxavir marboxil) official prescribing information.
[2] Centers for Disease Control and Prevention. (n.d.). TREATMENT FOR INFLUENZA: ANTIVIRAL DRUGS.
[3] DrugPatentWatch.com.